KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 220 filers reported holding KITE PHARMA INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $13,963,000 | +428.1% | 77,651 | +204.5% | 0.59% | +1410.3% |
| Q2 2017 | $2,644,000 | +5.9% | 25,500 | -19.8% | 0.04% | 0.0% |
| Q1 2017 | $2,496,000 | +51.3% | 31,800 | -13.6% | 0.04% | +34.5% |
| Q4 2016 | $1,650,000 | -62.0% | 36,800 | -57.6% | 0.03% | -56.7% |
| Q2 2016 | $4,340,000 | +117.9% | 86,800 | +100.0% | 0.07% | +103.0% |
| Q1 2016 | $1,992,000 | +6.4% | 43,400 | +42.8% | 0.03% | +13.8% |
| Q4 2015 | $1,873,000 | +315.3% | 30,400 | +275.3% | 0.03% | +262.5% |
| Q3 2015 | $451,000 | – | 8,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|